Should You Buy Illumina Stock in March?

If you've ever had your genome sequenced, there's a very high chance that your DNA has found its way into one of Illumina's (NASDAQ: ILMN) gene sequencing machines.

Biopharma companies, consumer genomics companies, and even primary care practices also use Illumina's products to perform research, diagnose illnesses, and inform the proper course of treatment. But does its ubiquitous presence in healthcare make its stock a good investment? Let's dive in and investigate.

Image source: Getty Images.

Source Fool.com